What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?
- 1 May 2013
- journal article
- review article
- Published by Elsevier in Journal of Chromatography A
- Vol. 1292, 19-24
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Drug Testing in the WorkplacePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012
- Current role of liquid chromatography coupled to mass spectrometry in clinical toxicology screening methodsClinical Chemistry and Laboratory Medicine (CCLM), 2011
- Current role of LC-MS(/MS) in doping controlAnalytical and Bioanalytical Chemistry, 2011
- Recent advances of liquid chromatography–(tandem) mass spectrometry in clinical and forensic toxicologyClinical Biochemistry, 2011
- Advanced Urine Toxicology TestingJournal of Addictive Diseases, 2010
- Mass spectrometric approaches in impaired driving toxicologyAnalytical and Bioanalytical Chemistry, 2008
- Bioanalytical procedures for determination of drugs of abuse in bloodAnalytical and Bioanalytical Chemistry, 2007
- Current role of liquid chromatography–mass spectrometry in clinical and forensic toxicologyAnalytical and Bioanalytical Chemistry, 2007
- Demands on scientific studies in clinical toxicologyForensic Science International, 2007
- Urine drug screening in the medical settingClinica Chimica Acta, 2002